Skip to content
Business Segments · Total reserve balance

North American Pharmaceutical — Total reserve balance

McKesson North American Pharmaceutical — Total reserve balance increased by 28.6% to $18M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 63.6%, from $11M to $18M.

Analysis

StatementSegment
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ4 2024
Last reportedQ4 2026May 8, 2026

How to read this metric

A decreasing balance suggests that restructuring programs are nearing completion, while an increasing balance indicates new or ongoing initiatives.

Detailed definition

This metric represents the cumulative liability balance set aside for specific restructuring or contingency programs wit...

Peer comparison

Similar to restructuring accruals found on the balance sheets of large diversified healthcare distributors.

Metric ID: mck_segment_north_american_pharmaceutical_total_reserve_balance

Historical Data

5 periods
 Q4 '24Q4 '25Q2 '26Q3 '26Q4 '26
Value$23M$11M$14M$14M$18M
QoQ Change-52.2%+27.3%+0.0%+28.6%
YoY Change-52.2%+63.6%
Range$11M$23M
CAGR-21.7%
Avg YoY Growth+5.7%
Median YoY Growth+5.7%
Current Streak3 quarters growth

Frequently Asked Questions

What is McKesson's north american pharmaceutical — total reserve balance?
McKesson (MCK) reported north american pharmaceutical — total reserve balance of $18M in Q1 2026.
How has McKesson's north american pharmaceutical — total reserve balance changed year-over-year?
McKesson's north american pharmaceutical — total reserve balance increased by 63.6% year-over-year, from $11M to $18M.
What does north american pharmaceutical — total reserve balance mean?
The total amount of funds currently held in reserve for future restructuring-related obligations in the North American Pharmaceutical segment.